Literature DB >> 7737384

Adenovirus infection induces rearrangements in the intranuclear distribution of the nuclear body-associated PML protein.

F Puvion-Dutilleul1, M K Chelbi-Alix, M Koken, F Quignon, E Puvion, H de Thé.   

Abstract

We have studied at the ultrastructural level the localization of PML protein in response to adenovirus infection in HeLa cells. In nuclei of noninfected cells or at the early stage of infection, PML accumulated at the border of nuclear bodies as previously described [Koken et al. (1994) EMBO J. 13, 1073-1083]. Interestingly, we demonstrate herein that PML is also a component of the interchromatin granule-associated zones, recently described structures containing U1 snRNP [Visa et al. (1993) Eur. J. Cell Biol. 60, 308-321], suggesting that PML protein might be involved in some steps of splicing events. However, as the infection progressed these two cellular PML-containing structures disappeared but significant amounts of PML accumulated within two virus-induced structures, essentially the clear amorphous inclusions, but also the protein crystals. Relocalization of this protein to virus-induced structures may reflect an inactivation of PML functions.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7737384     DOI: 10.1006/excr.1995.1125

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  33 in total

1.  Roles for the E4 orf6, orf3, and E1B 55-kilodalton proteins in cell cycle-independent adenovirus replication.

Authors:  F D Goodrum; D A Ornelles
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

2.  Functional analysis of adenovirus protein IX identifies domains involved in capsid stability, transcriptional activity, and nuclear reorganization.

Authors:  M Rosa-Calatrava; L Grave; F Puvion-Dutilleul; B Chatton; C Kedinger
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

Review 3.  Human pathogens and the host cell SUMOylation system.

Authors:  Peter Wimmer; Sabrina Schreiner; Thomas Dobner
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

4.  Adenovirus protein IX sequesters host-cell promyelocytic leukaemia protein and contributes to efficient viral proliferation.

Authors:  Manuel Rosa-Calatrava; Francine Puvion-Dutilleul; Pierre Lutz; Dominique Dreyer; Hugues de Thé; Bruno Chatton; Claude Kedinger
Journal:  EMBO Rep       Date:  2003-10       Impact factor: 8.807

Review 5.  PML nuclear bodies.

Authors:  Valérie Lallemand-Breitenbach; Hugues de Thé
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-04-21       Impact factor: 10.005

6.  Proteasome-dependent degradation of Daxx by the viral E1B-55K protein in human adenovirus-infected cells.

Authors:  Sabrina Schreiner; Peter Wimmer; Hüseyin Sirma; Roger D Everett; Paola Blanchette; Peter Groitl; Thomas Dobner
Journal:  J Virol       Date:  2010-05-19       Impact factor: 5.103

Review 7.  A guide to viral inclusions, membrane rearrangements, factories, and viroplasm produced during virus replication.

Authors:  Christopher Netherton; Katy Moffat; Elizabeth Brooks; Thomas Wileman
Journal:  Adv Virus Res       Date:  2007       Impact factor: 9.937

8.  The SP100 component of ND10 enhances accumulation of PML and suppresses replication and the assembly of HSV replication compartments.

Authors:  Pei Xu; Bernard Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  2017-04-24       Impact factor: 11.205

Review 9.  Long story short: p53 mediates innate immunity.

Authors:  Jessica Miciak; Fred Bunz
Journal:  Biochim Biophys Acta       Date:  2016-03-04

10.  A structural basis for the assembly and functions of a viral polymer that inactivates multiple tumor suppressors.

Authors:  Horng D Ou; Witek Kwiatkowski; Thomas J Deerinck; Andrew Noske; Katie Y Blain; Hannah S Land; Conrado Soria; Colin J Powers; Andrew P May; Xiaokun Shu; Roger Y Tsien; James A J Fitzpatrick; Jeff A Long; Mark H Ellisman; Senyon Choe; Clodagh C O'Shea
Journal:  Cell       Date:  2012-10-12       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.